An observational study in Hydrocephalus, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-05-11.
Sponsored by University of Pennsylvania · Observational
There have been reports in the past of using thermal cameras to demonstrate flow in the tubing as a surrogate of proper shunt function. This was shown to have almost 90% accuracy at determining proper functioning but required expensive equipment that was not universally available. There is now smart phone based thermal camera technology (Flir One: http://www.flir.com/flirone/) that could make this technique widely available for health care use. The goal of the study is to determine if this device can demonstrate flow in the distal tubing of a VP shunt.
190 studies on the registry are indexed under Hydrocephalus; 52 are open to participants now.
This study's enrollment of 2 is below the median of 73 across 86 observational studies indexed under Hydrocephalus.
Browse Hydrocephalus studies →University of Pennsylvania is the lead sponsor of 1,668 studies on the registry; 235 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 109 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients with VP shunts at the University of Pennsylvania, Department of Neurosurgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Determine if a smartphone based thermal camera can determine flow in the distal tubing of a VP shunt.
Time frame: 3 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2018 to primary completion in Nov 2019, 19 months.
Of 37 observational studies under Hydrocephalus, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 81. This study's 19 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.